Related Experiment Videos
An antidepressant-induced decrease in the responsiveness of hippocampal neurons to group I metabotropic glutamate
1Department of Physiology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, 31-343, Cracow, Poland.
European Journal of Pharmacology
|January 5, 2000
Summary
Repeated imipramine treatment reduces hippocampal neuron responsiveness to glutamate receptors. This desensitization, observed in rat CA1 neurons, may explain the delayed therapeutic effects of antidepressants.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Imipramine is a standard tricyclic antidepressant targeting serotonin and noradrenaline reuptake.
- Glutamate metabotropic receptors (mGluRs) play roles in neuronal excitability and synaptic plasticity.
- The effects of chronic antidepressant treatment on mGluR signaling in the hippocampus are not fully understood.
Purpose of the Study:
- To investigate the impact of imipramine on the responsiveness of CA1 hippocampal neurons to group I mGlu receptor activation.
- To explore the time course and duration of imipramine's effects on neuronal signaling.
Main Methods:
- Ex vivo electrophysiological recordings (extracellular and intracellular) in the CA1 area of rat hippocampus.
- Administration of imipramine (acute and repeated) and the group I mGlu receptor agonist DHPG.
- Assessment of neuronal excitability, including population spike amplitude, cell depolarization, and afterhyperpolarization.
Main Results:
- Acute imipramine did not alter DHPG's effects on neuronal excitability.
- Repeated imipramine treatment (14 days) significantly attenuated DHPG-induced increases in population spike amplitude, depolarization, and reduced afterhyperpolarization.
- These effects developed over 7-14 days of treatment and persisted for 7 days after drug withdrawal, without altering basic membrane properties.
Conclusions:
- Repeated imipramine administration decreases the responsiveness of CA1 hippocampal neurons to group I mGlu receptor activation.
- The time course of this desensitization correlates with the delayed onset of antidepressant action in humans.
- Alterations in mGlu receptor signaling may be a key mechanism underlying the therapeutic efficacy of antidepressants.